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1. Introduction
Acremonium chrysogenum, belongs to Filamentous fungi, is an important industrial microor‐
ganism. One of its metabolites, cephalosporin C (CPC), during fermentation is the major
resource for production of 7-amino cephalosporanic acid (7-ACA), an important intermediate
for the manufacture of many first-line anti-infectious cephalosporin-antibiotics, in industry.
Cephalosporins belong to the family of beta-lactam antibiotics. Comparing the first-discovered
penicillin, cephalosporins have obvious advantages since they are more stable to penicillinase
and are more effective to many penicillin-resistant strains. The incidence of adverse effects for
cephalosporins is also lower than that for penicillins and other anti-infectious agents. Thus,
cephalosporins are among the most-widely used anti-infectious drugs clinically. In China, the
research on cephalosporins started from the 1960s, and cefoxitin was first developed in 1970.
In the past 30 years, cephalosporin-antibiotics are one the most developed medicines on the
domestic market. They accounts for more than 40% of the anti-infectious drug market share.
As the major resource for manufacturing 7-ACA, the production and cost of CPC is of the
utmost importance in the cephalosporin-antibiotics market. The Ministry of Science and
Technology of China has listed the fermentation of CPC as the major scientific and technical
project in the past 30 years due to the continuous demand of strain improvement for the CPC-
producing Acremonium chrysogenum.
Because of the limitation of traditional techniques on strain improvement for A. chrysogenum,
along with the ubiquitous applications of molecular biology, genetic engineering has become
a powerful tool to manipulate the antibiotic producing strain and to obtain a high-yielding
mutant strain. This paper will summarize the most recent developments on genetic manipu‐
lation of A. chrysogenum.
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2. Biosynthesis of CPC
The industrialization of CPC fermentation has been established tens of years ago with the
breakthrough in key technologies including fermentation yield, fermentation regulation and
preparation and purification. Nevertheless, there has been a lot of publications, recently on
the improvement of CPC-producing strain by traditional methods, such as UV [1] or NTG
[2]mutagenesis, and optimization of fermentation process [3], as well. However, most of the
latest strain breeding techniques are at the molecular level, and the most important approach
has been the research on the biosynthesis of the target metabolite.
The biosynthesis of CPC during the fermentation of A. chrysogenum has been well investigated.
There are two gene clusters on the chromosome that are involved in the biosynthesis of CPC.
The “early” cluster consists of pcbAB-pcbC and cefD1-cefD2. The pcbAB-pcbC encode two
enzymes responsible for the first two steps in CPC biosynthesis [4]. While the cefD1-cefD2
encode proteins that epimerize isopenicillin N (IPN) to penicillin N [5]. The “late” cluster
consists of cefEF and cefG genes, which encode enzymes responsible for the last two steps [6].
The biosynthesis pathway of CPC is illustrated in figure 1. The ACV synthase, encoded by the
pcbAB gene, condenses 3 precursors L-α-aminoadipic acid, L-cysteine, L-valine to the ACV
tripeptide. The ACV is then cyclized into IPN by IPN synthase encoded by pcbC gene. The step
from IPN to penicillin N is catalyzed by a two-component epimerization system encoded by
cefD1-cefD2. The cefEF encodes a unique bi-functional enzyme, deacetyloxy-cephalosporin C
(DAOC) synthase-hydroxylase which successively transforms penicillin N into DAOC and
deacetyl-cephalosporin C (DAC). The last step in CPC biosynthesis is catalyzed by a DAC-
acetyltransferase (DAC-AT) which is encoded by cefG. The crystal structure of DAC-AT has
been published [7]. It has been shown that DAC-AT belongs to α/β hydrolase family according
to the formation of DAC-enzyme complex [7]. Among these, pcbAB, cefEF and cefG were
considered as the rate-limiting steps in CPC biosynthesis [8].
In recent years, some other regulatory proteins, which have been found to be important in CPC
biosynthesis, as well as their coding genes have been discovered. For example, AcveA, a
homologue of veA from Aspergillus, regulates the transcription of all 6 major CPC biosynthesis
genes including pcbAB, pcbC, cefD1, cefD2, cefEF and cefG. Disruption of AcveA leads to a
dramatic reduction of CPC yield.
A cefP gene located in the early cluster of CPC biosynthesis cluster has just been characterized.
This gene encodes a transmembrane protein anchored in a peroxisome. It regulates the
epimerization of IPN to penicillin N catalyzed by CefD1-CefD2 two-component enzyme
complex in peroxisome. The cefP disruptant accumulated IPN and lost CPC production [10].
To compensate for the disruption of cefP, both cefP and cefR need to be introduced simultane‐
ously. The CefR is the repressor of CefT, and stimulates the transcription of cefEF. A mutant
A. chrysogenum without cefR showed delayed transcription of cefEF and accumulation of
penicillin N resulted in reduction of CPC yield [11].
A cefM gene was also found downstream of cefD1. Disruption of cefM accumulates penicillin
N with no CPC production at all [12]. It is suggested that CefM may be involved in the
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translocation of penicillin N from the peroxisome to the cytoplasm. Without cefM, cells are
unable to transport penicillin N which gets epimerized in peroxisome into cytoplasm, from
where CPC is synthesized.
3. Techniques for molecular breeding
Acremonium chrysogenum belongs to the family of Filamentous fungi. The techniques for genetic
breeding are somehow difficult to manipulate due to its complicated structure of the cell wall
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Figure 1. The biosynthesis pathway of CPC
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and the special life cycle. Our laboratory has started the molecular breeding of A. chrysoge‐
num at a relatively early stage based on some published results from host, transformation,
homologuous recombination and selectable marker of A. chrysogenum [13, 14].
To introduce exogenous DNA into A. chrysogenum, a traditional PEG-mediated protoplast
transformation method is commonly used [15]. Since we are focusing on high-yield, or
industrial strains, which usually have a stronger restriction-modification system than type
strain, the traditional transformation method is not efficient enough for foreign gene intro‐
duction.
Agrobacterium tumefaciens mediated transformation has been widely used in plant genetic
engineering, and in some of the Filamentous fungi including Penicillium chrysogenum and
Aspergillus nidulans as well [17]. We have developed an adapted A. tumefaciens mediated
transformation protocol for A. chrysogenum, which has a higher transformation efficiency than
the PEG- mediated method [17], and more importantantly, this protocol can also be applied
in A. chrysogenum high-yield strain. This is the first report of A. tumefaciens mediated A.
chrysogenum transformation in the world.
Considering the significant improvement after introduction of vgb, VHb protein coding gene,
we use error-prone PCR together with DNA shuffling to artificially evolve the vgb gene in
vitro. After primary and secondary screening, a higher active mutant protein was obtained. E.
coli bearing this mutant VHb produce 50% more biomass than its counterpart bearing the
original VHb under limited oxygen environment [18].
A lot of basic research was done to facilitate the genomic DNA extraction [19] and endogenous
promoter capture [20] from the chromosome of A. chrysogenum. A notable progress is the
cloning of pcbAB-pcbC bi-directional promoter from the chromosome of A. chrysogenum [21].
This allows for the convenient manipulation of A. chrysogenum by introduction of multiple
genes.
The last step in CPC biosynthesis, DAC transformed into CPC catalyzed by DAC acetyltrans‐
ferase, was further investigated, as many reports have demonstrated that this is the rate-
limiting step while DAC acetyltransferase coding gene, cefG has a low transcription rate in
vivo. Our study showed that recombinant expressed DAC acetyltransferase can transform
DAC into CPC in vitro in the presence of acetyl CoA [22]. The enzymological and kinetic study
of the recombinant DAC acetyltransferase help us better understand the catalytic mechanism
of the enzyme and make it possible to improve its enzymatic activity in vivo [23].
4. Molecular breeding of Acremonium chrysogenum
Among the three rate-limiting enzymes, PcbAB is relatively difficult to manipulate due to its
larger coding gene. Thus, researchers focus on cefEF and cefG for molecular breeding of A.
chrysogenum. Besides, extra copy numbers of cefT could increase the yield of CPC in the mutant
A. chrysogenum [24]. And, overexpression of cefP and cefR in A. chrysogenum can decrease the
accumulation of penicillin N and promote the yield of CPC by about 50% [11].
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The fermentation process of A. chrysogenum is an extreme oxygen-consumption procedure. All
the rate-limiting enzymes are oxygen-requiring enzymes. The Vitreoscilla Hemoglubin (VHb)
is very attractive since it is capable of oxygen transmission in oxygen-limiting environments.
A recombinant strain bearing VHb can significantly improve the usage of oxygen during the
fermentation process and increase the product yield, which has been proven in Aspergillus [25].
Introduction of vgb, the coding gene for VHb, into A. chrysogenum can also maintain a higher
specific growth rate and specific production rate resulting in a 4-5 fold higher yield of the
mutant strain [26]. Actually, there are many industrial A. chrysogenum strains that express a
recombinant vgb.
The earliest report on genetic modification for A. chrysogenum was published in 1989, when
researchers from Eli Lilly Co. introduced an extra copy of cefEF-cefG fragment into A. chryso‐
genum which resulted in a 15%-40% higher producing mutant strain [27]. This was the first
evidence that molecular breeding could be a powerful tool in strain improvement of A.
chrysogenum.
Although controlled by the same bi-directional promoter, the transcription levels of cefEF and
cefG showed a huge difference as shown by RT-PCR. The transcription of cefG is much lower
than that of cefEF. This leads to the accumulation of DAC in the metabolites since they can not
be efficiently transformed into CPC. As a matter of fact, CPC/DAC ratio is a quality control
parameter in the industrial production of CPC fermentation. Thus, the introduction of extra
copy numbers of cefG produced an engineering strain whose CPC yield is 3 folds higher than
the parental strain [28].
There is another report on the introduction of cefT into A. chrysogenum,where the resulting
mutant doubled the CPC yield [29]. This could be attributed to the enhancement of CefT, the
efflux pump protein, so that the feedback inhibition in vivo triggered by the fermentation
product was attenuated, resulting in a higher product yield.
Using molecular breeding technology, some CPC derivatives can be directly produced by
engineering A. chrysogenum fermentation. For example, by disruption of cefEF and introduction
of cefE originating from Streptomyces clavuligerus, a novel DAOC producing strain was
obtained, which if followed by two enzymatic transformations, the industrially important 7-
ADCA can be produced [30]. By introduction of the coding genes simultaneously into A.
chrysogenum for the two enzymes used the industrial production of 7-ACA by immobilized
enzymatic transformation, the engineering strain can produce 7-ACA by fermentation [31].
Besides the introduction of exogenous genes, disruption and/or silencing of the endogenous
genes is also a common strategy for genetic breeding of a certain strain. The recently developed
RNA interference (RNAi) technique can be used as an alternative to silence the transcription
of target genes instead of homologous recombination. RNAi in A. chrysogenum was first
published in 2007 [32]. The latest report was silencing of pcbC gene in Penicillium chrysoge‐
num and cefEF gene in A. chrysogenum by RNAi [33]. These reports demonstrated the feasibility
of RNAi technique in Filamentous fungi.
There is another interesting research for the molecular breeding of A. chrysogenum in a different
idea. As we mentioned before, CefD1-CefD2 is a two-component enzyme complex that
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transforms IPN into penicillin N by an epimerization system located in the peroxisome. cefD1-
cefD2 block mutant lacking this epimerization system accumulated a large amount of IPN to
more than 650μg/mL, almost the total relative CPC yield. With this mutant, the unstable IPN,
which has never been purified before, could be now be purified by several steps using
chromatography [34]. Characterization of its half-life and stability under a variety conditions
can greatly help in the investigation of IPN.
It is worth noting that all of the above genetic breeding reports were on the background of an
A. chrysogenum type strain C10, whose CPC yield is only 1 mg/mL, far less than the industrial
production level. Although some good achievements were obtained in improvement of A.
chrysogenum fermentation and modification of metabolic products, those achievements are still
far away from application in industry.
5. Industrialization research on molecular breeding of A. chrysogenum
Our research is focused on the molecular breeding of A. chrysogenum high-yield and/or
industrial strains. We introduced different combinations of cefG/cefEF/cefT/vgb genes into CPC
high-producing strain and found that an extra copy of cefG has a significant positive effect on
CPC fermentation level. Since random integration occurring in A. chrysogenum, different
transformants with cefG introduction showed different elevated levels, with some at 100%. An
extra copy of vgb gene also displayed a significant improvement up to 30% more of the CPC
yield. Meanwhile, introduction of cefEF and cefT has no obvious effect on CPC production in
the high-yield strain [35]. This revealed the apparent discrepancy between the genetic
background of the type strain and the high-yield strain, and also suggested that endogenous
cefEF and cefT may already achieve high bioactivity after several rounds of mutagenesis
breeding that a high-yield strain usually undertaken.
We then applied this achievement to a CPC industrial strain. Although we didn’t obtain a
mutant that doubled the CPC yield, we did obtain an engineering strain whose CPC yield was
increased by 20%, which has a promising industrialized potential.
We also tried the RNAi technique in the high-yield strain. A plasmid vector containing cefG
double strain RNA transcription unit was constructed and transformed into high-yield A.
chrysogenum. The cefG transcription level in the transformants was measured by quantitative
RT-PCR. Two mutant strains were found to have a decreasing cefG transcription level of up to
80%. Their CPC yield was also found to decrease by 34.6% and 28.8%, respectively [36]. This
result demonstrated the feasibility of RNAi application in high-yield A. chrysogenum and
possible, industrial strain. Moreover, this is important for metabolic pathway reconstitution
and novel CPC derivatives fermentation in A. chrysogenum.
The fermentation product of A. chrysogenum, CPC, is the major resource for industrial manu‐
facturing of 7-ACA, the important intermediate of a large variety of cephalosporins antibiotics.
A common producing route of 7-ACA is the chemical semi-biosynthesis. To date, the more
environmental-friendly biotransformation has been widely used in industry. Although two
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step transformation dominates in the market [37], research on one step transformation from
CPC to 7-ACA is still hot. However, the substrate specificity of CPC acylase still remains
unsolved [38].
Whether two-step or one-step, fermentation of CPC is the prerequisite followed by enzymatic
biotransformation in vitro. We are thinking of introducing CPC acylase gene into A. chrysoge‐
num to construct the engineering strain that can produce 7-ACA directly by fermentation, a
breakthrough in the production of 7-ACA.
A CPC acylase gene was designed according to the codon bias of A. chrysogenum and intro‐
duced into an industrial strain. Our result showed that this CPC acylase was expressed in A.
chrysogenum with bioactivity. The recombinant acylase can transform the original product CPC
into 7-ACA in vivo, makes the engineering strain capable of direct fermentation of 7-ACA.
Based on enzymological profiles of CPC acylase in vitro, we performed a preliminary optimi‐
zation of medium composition and culture condition and the CPC yield was increased
significantly with as least 30% of the CPC fermented being transformed into 7-ACA [40]. We
believe this in vivo conversion can be more effective if a more powerful transcription cassette
and more copy number can be introduced, with the incorporation of traditional breeding
technology, and finally, bring this technique to industry.
6. Perspectives
As a novel tool for strain improvement, genome shuffling is of widespread concern in the field
of industrial microbiology since it was first reported [41]. This has been applied in Bacteria
and Streptomyces, and the yield of a lot of metabolites got a substantial increase by genome
shuffling. However, genome shuffling in Filamentous fungi is rare, maybe due to the unde‐
veloped genetic manipulation system. In 2009, the cellulase production in Penicillin decum‐
bens was reported to be increased by 40% with the help of genome shuffling [42]. But this
achievement resulted largely in primary metabolites. As we all know, the regulation of
secondary metabolites, as well as the genetic manipulation of A. chrysogenum is much more
complicated. Since the exogenous genes were randomly integrated in the chromosome of A.
chrysogenum, we suggest that genome shuffling can effectively improve the fermentation of
the strains based on the established genetic techniques in our laboratory.
The biosynthesis of CPC in A. chrysogenum has been investigated thoroughly. However, the
mechanism of its regulation as well as the biosynthesis of precursors in primary metabolism
is still unclear [43]. The full sequence of A. chrysogenum is yet to be completed, although there
are more than 10 species belonging to the Filamentous fungi that have already been sequenced
[44]. To better understand the genetic basis of A. chrysogenum, we realize that comparative
proteomics could be used to study the molecular breeding without the genomic sequence of
A. chrysogenum. By identifying those different expressed proteins during CPC fermentation,
fermentation may be proposed based on the popular theory of metabolic engineering and
system biology [45].
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Besides its use in studying the mechanism of disease development, the application of compa‐
rative proteomics in antibiotic-producing microorganisms also showed promise. For instance,
345 different proteins were identified as critical during the conversion from primary to
secondary metabolism in Streptomyces coelicolor [46]. Another example is research on Penicillin
chrysogenum where 950 proteins involved in precursor biosynthesis, stress response and
pentose phosphate pathway were found to be related to the fermentation yield in 3 penicillin-
producing strains [47].
Thus, we believe that the molecular breeding of A. chrysogenum should consist of genome
shuffling, optimization of secondary metabolism, improvement of precursor biosynthesis and
energy metabolism as well. Although there are still big effects need to be put in the basic and
practical research of A. chrysogenum, the molecular bred engineering strains will play an
important role in the industrial production of CPC and its derivatives.
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